2nd Quarter - Report

ZIMMER BIOMET, INC. for ZIMMER BIOMET, INC.

Period 2nd Quarter 2017 Filed Jul 20, 2017 Signed by Whitney Tull

Official filing
Firm
ZIMMER BIOMET, INC.
Client
ZIMMER BIOMET, INC.
Income
—
Expenses
$190,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

MDUFA Reauthorization (HR 2430 S934), FDA Inspections (HR1736 S404), MDET repeal

LobbyistCovered position, as disclosed
CHRISTOPHER A CERONE —
WHITNEY TULL —

Contacted: SENATE; U.S. Trade Representative (USTR); Commerce, Dept of (DOC); HOUSE OF REPRESENTATIVES

Bills named: H.R. 2430 (115th), H.R. 1736 (115th)

Trade (domestic/foreign) TRD

NAFTA Renegotiation, India price controls

LobbyistCovered position, as disclosed
CHRISTOPHER A CERONE —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); U.S. Trade Representative (USTR)

Taxation/Internal Revenue Code TAX

MDET repeal, tax reform

LobbyistCovered position, as disclosed
CHRISTOPHER A CERONE —
WHITNEY TULL —

Contacted: HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); U.S. Trade Representative (USTR); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.